Novartis India Q2 Results Live : Novartis India declared their Q2 results on 25 October 2024, reporting a topline increase of 10.59% year-over-year. However, the company faced challenges as profit decreased by 13.81% in the same period.
In comparison to the previous quarter, Novartis experienced a decline in revenue by 5.62% and a significant drop in profit by 20.71%. This indicates potential headwinds the company may need to address moving forward.
Notably, the Selling, General & Administrative (SG&A) expenses saw a positive trend, declining by 5.97% quarter-over-quarter and by 3.17% year-over-year. This reduction could be a strategic move to enhance profitability amid rising costs.
The operating income reported a decrease of 25.79% from the previous quarter, although it did show an increase of 6.89% year-over-year. This mixed performance highlights the ongoing volatility in operational efficiency.
Earnings Per Share (EPS) for Q2 stood at ₹8.27, reflecting a decrease of 13.76% year-over-year, which may concern investors looking for consistent growth.
In terms of stock performance, Novartis India has delivered a -4.82% return over the last week, a modest 1.07% return over the past six months, and an impressive 36.7% year-to-date return, suggesting a mixed sentiment among investors.
As of now, Novartis India holds a market capitalization of ₹2609.94 crore, with a 52-week high of ₹1248 and a low of ₹599.95, indicating significant fluctuations in its stock price over the year.
Novartis India Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 87.1 | 92.29 | -5.62% | 78.76 | +10.59% |
| Selling/ General/ Admin Expenses Total | 5.2 | 5.53 | -5.97% | 5.37 | -3.17% |
| Depreciation/ Amortization | 0.58 | 0.55 | +5.45% | 0.65 | -10.77% |
| Total Operating Expense | 69.72 | 68.87 | +1.23% | 62.5 | +11.55% |
| Operating Income | 17.38 | 23.42 | -25.79% | 16.26 | +6.89% |
| Net Income Before Taxes | 27.56 | 33.68 | -18.17% | 32.43 | -15.02% |
| Net Income | 20.41 | 25.74 | -20.71% | 23.68 | -13.81% |
| Diluted Normalized EPS | 8.27 | 10.42 | -20.63% | 9.59 | -13.76% |
